ALPHA PARTICLE THERAPY OF SOLID TUMOURS (NON LEAD)

Grant number: 1143710 | Funding period: 2018 - 2020

Completed

Abstract

Alpha-particles linked to recombinant antibodies targeting tumour cells have potential to effectively treat tumours while minimising normal tissue side effects. We will explore a novel alpha-particle therapy approach to solid tumours, by delivering 225Ac directly into tumour cells, or into cells that support the tumour (microenvironment). This approach will hopefully result in development of a new approach to treatment of cancers that are resistant to conventional therapies.

University of Melbourne Researchers